Cordycepin alleviates metabolic dysfunction-associated liver disease by restoring mitochondrial homeostasis and reducing oxidative stress via Parkin-mediated mitophagy

Hai-Ying Tian ^a1, Dao-Jiang Yu ^ab1, Teng Xie ^a, Meng-Xia Xu ^a, Yu-Hao Wang ^a, Xi-Lu Sun ^a, Xin-Meng Zhou ^a, Ying-Xuan Han ^a, Qing-Qing Liao ^a, Yu-Jie Zhao ^c, Juan Liao ^a, Mohamed El-Kassas ^def, Xiao-Dong Sun ^ac

, Yuan-Yuan Zhang ^abaWest China School of Pharmacy, West China School of Basic Medical Sciences & Forensic Medicine, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 610041, China^bThe Second Affiliated Hospital of Chengdu Medical College, China National Nuclear Corporation 416 Hospital, Chengdu 610051, China^cMedical College, Tibet University, Lhasa 850000, China^dEndemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt^eLiver Disease Research Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia^fSteatotic Liver Disease Study Foundation in Middle East and North Africa (SLMENA), Cairo, Egypt

Received 18 August 2024, Revised 1 December 2024, Accepted 7 January 2025, Available online 8 January 2025, Version of Record 13 January 2025.

Full Article Here: https://www.sciencedirect.com/science/article/pii/S0006295225000127?via%3Dihub